Clinical Trials
15 trialsNCT03115476 2025-03-11
A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
LEO Pharma
Phase 3 Terminated
NCT03643744 2024-12-19
Photodynamic Therapy-Induced Immune Modulation: Part III
Wright State University
Phase 1 Terminated
NCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
NCT03963102 2024-07-26
Duration of Ameluz Application in Acral Actinic Keratoses Response
Royal Cornwall Hospitals Trust
Phase 4 Terminated
NCT04269395 2023-10-10
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
Galderma R&D
Phase 3 Terminated
NCT01525329 2022-03-15
Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease
The Cleveland Clinic
Phase 3 Terminated
NCT03996252 2020-12-07
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
Tulane University
Phase EARLY_PHASE1 Terminated
NCT02150863 2019-11-18
Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Massachusetts General Hospital
Phase NA Terminated
NCT02473848 2018-07-19
IMOT001
University of Zurich
Phase 3 Terminated
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT00524485 2017-06-14
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Roswell Park Cancer Institute
Phase NA Terminated
NCT01806961 2016-08-03
Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
Spirig Pharma Ltd.
Terminated
NCT01532453 2016-01-08
Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients
Spirig Pharma Ltd.
Phase 3 Terminated
NCT01203878 2014-12-08
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Tennessee Clinical Research Center
Phase 4 Terminated
NCT00865878 2011-10-21
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
DUSA Pharmaceuticals, Inc.
Phase 2 Terminated